Clinical updates, including trial initiations, enrollment status and data readouts and publications: Acer, Acticor, Amgen, Amo, Apogenix, Ascentage, Astellas, Astrazeneca, Biocryst, Bone, Cardiol, Chemocentryx, Curevac, Fibrogen, Gannex, GW, Kiniksa, Maat, Mapi, Mitsubishi Tanabe, Molecular Templates, Oncopeptides, Ose, Redhill, Rhythm, Soligenix, Synthetic Biologics, Tonix, UItimovacs, Vifor, Vicore.